UBS raises DaVita target to $287
The sizable target-to-price gap is notable, but remains an analyst forecast rather than a certainty.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
The sizable target-to-price gap is notable, but remains an analyst forecast rather than a certainty.
What happened, with direct paths to the underlying reporting
UBS raised its DVA price target to $287 versus a posted price of $187.50, indicating a materially bullish analyst outlook.
Target: $287
Posted price: $187.5
Analyst firm: UBS
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.